Follow The Filings

MRVI position history

The shares of Maravai Lifesciences (MRVI) that First Eagle Investment Management, LLC reported in each quarter’s 13F.

Equity, COM CL A

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q3: 450,931 shares, $1.3M, <0.01% of portfolio, New
  2. 2025 Q4: 1,799,336 shares, $5.8M, 0.01% of portfolio, Add +299.0%
  3. 2026 Q1: 5,048,672 shares, $14M, 0.02% of portfolio, Add +180.6%
  4. 2026 Q2: 3,671,287 shares, $23M, 0.04% of portfolio, Reduce −27.3%
Holdings date Value % of holdings Shares Filing date All 13F holders